Starazolin Eye drops 2x5 ml

€5.31
VAT included
Quantity
3
Out-of-Stock

family :'Nunito Sans', sans-serif;font-size:14px;background-color:#ffffff;">

Product description

starezolin #starazolin" target="_blank" style="margin:0px;padding:0px;border:0px;color:#000000;" rel="noreferrer noopener">Starazolin is a drug for adults and children over 2 years of age indicated for use in the symptomatic treatment of conditions accompanied by swelling and hyperemia of the conjunctiva caused by irritants such as: dust, smoke, contact lenses, wind, bright light, chlorinated water and cosmetics.The drug can also be used in allergic inflammatory conditions, such as: hay fever and grass pollen allergy.Starazolin soothes burning, itching, soreness, excessive tearing and irritation.

Indications

Swelling and hyperemia of the conjunctiva, as well as allergic inflammations, such as: hay fever and allergy to grass pollen, eye fatigue.

Composition

1 ml contains:

  • active substance: tetryzoline hydrochloride 5 mg,
  • excipients: sodium chloride, disodium edetate, benzalkonium chloride, sodium tetraborate, boric acid, purified water.

Action

Reducing conjunctival congestion and swelling, alleviating burning, itching, pain, excessive tearing and irritation.

Dosage

Always use this medicine exactly as described in the package leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • Adults and children over 2 years of age: 1-2 drops of the drug, 2 to 3 times a day.
  • The drug is applied topically to the conjunctival sac.
  • Do not use while wearing contact lenses.

The medicine can be used within 28 days of first opening the bottle. Starazolin is a sterile liquid. Do not touch the tip of the dropper, and after instillation, immediately close the bottle tightly. In the case of disposable containers, tear the container from the leaf. Twist the elongated end of the reservoir, then gently press the reservoir, and instill the squeezed drops into the eye (eyes) after discarding the first two drops. The amount remaining after instillation is not suitable for further use. Contact lenses should be removed before use and reinserted approximately 15 minutes after instillation.

Contraindications

  • Hypersensitivity to tetryzoline or any ingredient of this drug.
  • Do not use in children under 2 years of age.
  • Glaucoma, especially with narrow-angle or other severe eye conditions.

Storage

Store at a temperature of up to 25ºC, out of the sight and reach of children.

Side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

  • Excessive use (for too long or too often) may lead to sore or burning eyes, reactive congestion, blurred vision, conjunctival irritation or, rarely, dilated pupils. In isolated cases, the drug may exert systemic sympathomimetic effects (increase in blood pressure, faster heartbeat, faster breathing).

Common (fewer than 1 in 10 patients):

  • reactive hyperemia,
  • burning of the mucous membranes,
  • dry mucous membranes,
  • systemic effects (e.g. palpitations, headaches, tremors, weakness, excessive sweating, increased blood pressure).

Very rare (fewer than 1 in 10,000 patients):

  • hyperkeratosis of the conjunctiva with closure of the lacrimal points and excessive lacrimation.

Blurred vision, conjunctival irritation, rarely mydriasis may occur. There is a risk, especially in newborns and children up to 2 years of age, of symptoms associated with the absorption of the drug, including after swallowing it. The most important side effects are: central nervous system disorders, such as increased blood pressure, arrhythmias, tachycardia (rapid heartbeat), tachyarrhythmia (irregular heartbeat), reactive bradycardia (slow heartbeat).

interactions

Tell your doctor or pharmacist about all the medicines you are taking, have recently taken, or might take.

  • The drug used simultaneously with MAO inhibitors or tricyclic antidepressants, guanethidine or reserpine may increase blood pressure. When using these drugs, the drug can only be used after consulting a doctor.
  • When anesthetics, insulin, atropine sulphate or propranolol are used concomitantly with tetryzoline, the effect of these drugs on the circulatory system may be intensified.
  • When using other eye drops at the same time, there should be a 15-minute interval between instillations.

Warnings and precautions

  • Talk to your doctor or pharmacist before taking this medicine.
  • Treatment should be discontinued if signs of inflammation worsen while using the drug.
  • The drug is intended for the treatment of conjunctival irritation of moderate intensity only.
  • It is not recommended to use the drug during infection, corneal damage or during severe pain.
  • The patient should stop taking the medicine and contact the doctor if there is no clear improvement after two days of taking the medicine.
  • Long-term use of the drug may cause secondary irritation and hyperemia, symptoms of burning and stinging, as well as atrophic changes caused by chronic hypoxia of the eye mucosa.
  • Caution should be exercised in patients with severe cardiovascular disease (e.g. coronary artery disease) and hypertension, pheochromocytoma, in patients with diabetes mellitus and hyperthyroidism, treated with monoamine oxidase inhibitors and other drugs that may increase blood pressure.
  • Wearing soft contact lenses should be discontinued while using the drug.
  • The drug in the recommended dosage does not cause mydriasis, but there is a risk of mydriasis when used excessively, especially in patients with a light (blue) iris.
  • If you experience severe eye pain, headache, loss of vision, sudden appearance of moving spots in your field of vision, sudden redness of the eyes, pain caused by light, or double vision, contact your doctor immediately.
  • The drug is not effective in the treatment of delayed allergic reactions, such as contact inflammation of the conjunctiva and eyelid skin.

Use in children and adolescents

  • Long-term use of the drug should be avoided, especially in children.
  • The use of the drug in children under 2 years is contraindicated

Pregnancy

  • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
  • The safety of tetryzoline during pregnancy has not been established.
  • Starazolin can be used during pregnancy only if, in the opinion of the doctor, it is absolutely necessary.

Breast-feeding

  • There are no data on the excretion of tetryzoline in breast milk.
  • Breast-feeding women should use the drug with great caution and after weighing the risks and benefits of treatment by the physician.

Driving and using machines

  • There are no data on the effect of the drug on the ability to drive and use machines, however, conjunctivitis, mydriasis and blurred vision should be taken into account, which may limit psychophysical performance. If this happens, do not drive or operate machinery.

The drug contains benzalkonium chloride

  • This medicine contains 0.1 mg of benzalkonium chloride in each ml of solution. Benzalkonium chloride may be absorbed by soft contact lenses and discolour them. Remove contact lenses before instillation and wait at least 15 minutes before reinsertion.
  • Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or problems with the cornea (the clear layer at the front of the eye). If you experience abnormal sensations in the eye, stinging or pain in the eye after using the medicine, contact your doctor.
102225

Specific References

ean13
5903060

Starazolin Eye drops 2x5 ml

€5.31
group_work Cookie consent